Guilin Sanjin Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Guilin Sanjin Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guilin Sanjin Pharmaceutical Co Ltd (002275) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.62 Million ≈ $17.21 Million USD) by net assets (CN¥3.24 Billion ≈ $474.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002275 company net worth for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)

Cash flow conversion efficiency of Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024. This chart illustrates how Guilin Sanjin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guilin Sanjin Pharmaceutical Co Ltd (002275) share price today for real-time trading data and today's change.

Guilin Sanjin Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Guilin Sanjin Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Guilin Sanjin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guilin Sanjin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review free cash flow generation of Guilin Sanjin Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Xinjiang Xuefeng Sci-Tech SHG:603227	0.052x
Total Gabon F:RZW	0.045x
Supply Network Ltd AU:SNL	0.113x
Excelerate Energy Inc NYSE:EE	0.077x
Tekla Healthcare Investors NYSE:HQH	0.008x
Guangdong Golden Dragon Development Inc SHE:000712	0.130x
Metsa Board Oyj B HE:METSB	-0.005x
PNC Process Systems Co Ltd SHG:603690	0.012x

Annual Cash Flow Conversion Efficiency for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024. Also see balance sheet size of Guilin Sanjin Pharmaceutical Co Ltd for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.01 Billion ≈ $440.42 Million	CN¥588.33 Million ≈ $86.09 Million	0.195x	+0.25%
2023-12-31	CN¥2.82 Billion ≈ $412.21 Million	CN¥549.25 Million ≈ $80.37 Million	0.195x	+3.76%
2022-12-31	CN¥2.81 Billion ≈ $411.68 Million	CN¥528.67 Million ≈ $77.36 Million	0.188x	+30.08%
2021-12-31	CN¥2.84 Billion ≈ $415.55 Million	CN¥410.24 Million ≈ $60.03 Million	0.144x	-28.52%
2020-12-31	CN¥2.96 Billion ≈ $433.00 Million	CN¥597.99 Million ≈ $87.50 Million	0.202x	+21.50%
2019-12-31	CN¥2.82 Billion ≈ $411.99 Million	CN¥468.29 Million ≈ $68.52 Million	0.166x	-15.39%
2018-12-31	CN¥2.81 Billion ≈ $410.70 Million	CN¥551.73 Million ≈ $80.73 Million	0.197x	+34.52%
2017-12-31	CN¥2.65 Billion ≈ $388.35 Million	CN¥387.82 Million ≈ $56.75 Million	0.146x	-33.97%
2016-12-31	CN¥2.43 Billion ≈ $354.94 Million	CN¥536.85 Million ≈ $78.56 Million	0.221x	+30.14%
2015-12-31	CN¥2.34 Billion ≈ $342.87 Million	CN¥398.50 Million ≈ $58.31 Million	0.170x	-0.47%
2014-12-31	CN¥2.32 Billion ≈ $339.57 Million	CN¥396.53 Million ≈ $58.02 Million	0.171x	+19.83%
2013-12-31	CN¥2.20 Billion ≈ $322.38 Million	CN¥314.16 Million ≈ $45.97 Million	0.143x	-2.08%
2012-12-31	CN¥2.08 Billion ≈ $304.06 Million	CN¥302.59 Million ≈ $44.28 Million	0.146x	-15.34%
2011-12-31	CN¥1.98 Billion ≈ $290.15 Million	CN¥341.05 Million ≈ $49.91 Million	0.172x	+8.44%
2010-12-31	CN¥1.80 Billion ≈ $263.37 Million	CN¥285.49 Million ≈ $41.78 Million	0.159x	-22.16%
2009-12-31	CN¥1.78 Billion ≈ $260.89 Million	CN¥363.29 Million ≈ $53.16 Million	0.204x	-16.01%
2008-12-31	CN¥787.10 Million ≈ $115.18 Million	CN¥190.97 Million ≈ $27.94 Million	0.243x	+7.63%
2007-12-31	CN¥729.25 Million ≈ $106.71 Million	CN¥164.39 Million ≈ $24.06 Million	0.225x	-35.03%
2006-12-31	CN¥627.33 Million ≈ $91.80 Million	CN¥217.67 Million ≈ $31.85 Million	0.347x	--

About Guilin Sanjin Pharmaceutical Co Ltd

SHE:002275 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.06 Billion

CN¥7.27 Billion CNY

Market Cap Rank

#8403 Global

#1918 in China

Share Price

CN¥12.38

Change (1 day)

+2.57%

52-Week Range

CN¥12.03 - CN¥15.61

All Time High

CN¥19.61